Study Finds Limited Clinical Benefit for Cancer Drugs Approved Under FDA's Accelerated Approval Pathway

Health Nyheter

Study Finds Limited Clinical Benefit for Cancer Drugs Approved Under FDA's Accelerated Approval Pathway
Cancer DrugsFDAAccelerated Approval Pathway
  • 📰 Medscape
  • ⏱ Reading Time:
  • 33 sec. here
  • 8 min. at publisher
  • 📊 Quality Score:
  • News: 38%
  • Publisher: 55%

A new study reveals that less than half of the cancer drugs approved under the FDA's accelerated approval pathway have been shown to improve overall survival or quality of life, despite being on the market for more than 5 years.

SAN DIEGO — Fewer than half of the cancer drugs approved under the US Food and Drug Administration's accelerated approval pathway between 2013 and 2017 have been shown to improve overall survival or quality of life , despite being on the US market for more than 5 years, according to a new study.

The problem with relying on surrogate markers for drug approvals is that they don't always correlate with longer survival or improved quality of life, said Edward Cliff, MBBS, who presented the findings at the American Association for Cancer Research 2024 annual meeting . The study was also published in

The reliance on surrogate markers means that these drugs are used for treatment, covered by insurance, and added to guidelines — all without solid evidence of real-world clinical benefit, said Cliff. But the solution is not to curtail approvals; it's to make sure that accelerated approval commitments are met, said Kummar.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

Medscape /  🏆 386. in US

Cancer Drugs FDA Accelerated Approval Pathway Overall Survival Quality Of Life Confirmatory Trials

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Many cancer drugs remain unproven years after FDA's accelerated approval, study findsMany cancer drugs remain unproven years after FDA's accelerated approval, study findsThe FDA's accelerated approval program is meant to give patients early access to promising drugs, but a new study found most cancer drugs do not demonstrate benefits within five years.
Les mer »

Study finds 129,000 Chicago children under 6 have been exposed to lead-contaminated waterStudy finds 129,000 Chicago children under 6 have been exposed to lead-contaminated waterStudy finds 129,000 Chicago children exposed to lead-contaminated water
Les mer »

Parents have a problem with screen time, too, teens sayAlmost half of teenagers think their parents sometimes get distracted by their phones, Pew study finds.
Les mer »

UK rabbit owners can recognize pain in their pets, study findsUK rabbit owners can recognize pain in their pets, study findsRabbits are popular family pets, with around 1.5 million in the UK and it is important that owners recognize when their animal is in pain, and know when to seek help to protect their rabbit's welfare.
Les mer »

Abortions outside medical system increased sharply after Roe fell, study findsAbortions outside medical system increased sharply after Roe fell, study findsResearchers reported that volunteer-led networks distributing abortion pills helped drive a rise in “self-managed” abortions.
Les mer »



Render Time: 2025-02-26 22:05:40